Neuroepidemiology - 1st Edition - ISBN: 9780128029732, 9780128029909

Neuroepidemiology, Volume 138

1st Edition

Series Volume Editors: Caterina Rosano M. Arfan Ikram Mary Ganguli
eBook ISBN: 9780128029909
Hardcover ISBN: 9780128029732
Imprint: Elsevier
Published Date: 20th September 2016
Page Count: 352
Tax/VAT will be calculated at check-out Price includes VAT (GST)
25% off
25% off
25% off
25% off
25% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
30% off
30% off
30% off
30% off
30% off
20% off
20% off
275.00
206.25
206.25
206.25
206.25
206.25
220.00
220.00
170.00
119.00
119.00
119.00
119.00
119.00
136.00
136.00
200.00
140.00
140.00
140.00
140.00
140.00
160.00
160.00
Unavailable
Price includes VAT (GST)
× DRM-Free

Easy - Download and start reading immediately. There’s no activation process to access eBooks; all eBooks are fully searchable, and enabled for copying, pasting, and printing.

Flexible - Read on multiple operating systems and devices. Easily read eBooks on smart phones, computers, or any eBook readers, including Kindle.

Open - Buy once, receive and download all available eBook formats, including PDF, EPUB, and Mobi (for Kindle).

Institutional Access

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

SECTION 1 Principles and foundations of epidemiology and neurology research

1. Epidemiology for the clinical neurologist
    M.E. Jacob and M. Ganguli (Pittsburgh, USA)

2. Population neuroscience
    T. Paus (Toronto, Canada and New York, USA)

3. Advanced epidemiological analytical methods
    E. Albanese (Geneva, Switzerland)

4. Basics of neuroanatomy and neurophysiology
    C.K. Barha, L.S. Nagamatsu and T. Liu-Ambrose (Vancouver and London, Canada)

5. Population imaging in neuroepidemiology
    M.W. Vernooij, M. de Groot and D. Bos (Rotterdam, the Netherlands)

6. Use of “omics” technologies to dissect neurological disease
    G. Tosto and C. Reitz (New York, USA)

7. Neuropsychological assessment
    P. Palta, B. Snitz and M.C. Carson (Chapel Hill, Pittsburgh and Baltimore, USA)

SECTION 2 Epidemiology of disorders primarily affecting the nervous system

8. Dementias
    S. Sacuiu (Gothenburg, Sweden)

9. Epidemiology of alphasynucleinopathies from Parkinson disease to dementia with Lewy bodies
    R. Savica, B.F. Boeve and G. Logroscino (Rochester, USA)

10. Epidemiology of epilepsy
      S. Abramovici and A. Bagić (Pittsburgh, USA)

11. The epidemiology of multiple sclerosis: insights to a causal cascade
      D.S. Goodin (San Francisco, USA)

12. Neuroepidemiology of traumatic brain injury
      A.J. Gardner and R. Zafonte (Callaghan, Australia and Boston, USA)

13. The epidemiology of amyotrophic lateral sclerosis
      E.O. Talbott, A.M. Malek and D. Lacomis (Pittsburgh and Charleston, USA)

14. Cerebrovascular disease
      M.L.P. Portegies, P.J. Koudstaal and M.A. Ikram (Rotterdam, the Netherlands)

15. Peripheral neuropathies
      R. Hanewinckel, M.A. Ikram and P.A. van Doorn (Rotterdam, the Netherlands)

16. Migraine
      K.R. Peck, Y.L. Johnson and T.A. Smitherman (Oxford, USA)

SECTION 3 Neurocognitive consequences of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors

17. Neuroepidemiology of cancer and treatment-related neurocognitive dysfunction in adult-onset cancer patients and survivors
      P. Jean-Pierre and B.C. McDonald (Notre Dame and Indianapolois, USA)

18. Sickle cell disease
      J. Strouse (Baltimore, USA)


 


Description

Neuroepidemiology covers the foundations of neuroepidemiological research and the epidemiology of disorders primarily affecting the nervous system, as well as those originating outside the nervous system. The etiology of many important central nervous system disorders remains elusive. Even with diseases where the key risk determinants have been identified, better prevention and therapy is needed to reduce high incidence and mortality. Although evolving technologies for studying disease provide opportunities for such, it is essential for researchers and clinicians to understand how best to apply such technology in the context of carefully characterized patient populations.

By paying special attention to methodological approaches, this volume prepares new investigators from a variety of disciplines to conduct epidemiological studies in order to discern the etiologic factors and underlying mechanisms that influence the onset, progression, and recurrence of CNS disorders and diseases. The book also provides current information on methodological approaches for clinical neurologists seeking to expand their knowledge in research.

Key Features

  • Includes coverage of the foundations of neuroepidemiological research and the epidemiology of disorders primarily affecting the nervous system, as well as those originating outside the nervous system
  • Describes the most recent methodologies to define and quantify the burden of CNS disorders and to understand the underlying mechanisms, with neuroimaging and molecular methods receiving particular emphasis
  • Offers extensive description of those neurological conditions that are secondary to other diseases whose incidence is on the rise because of longer survival rates
  • Features chapters authored by leaders in the field from around the globe

Readership

Researchers, clinicians and advanced students in the fields of neurology, psychiatry, neuropsychology, genetics and clinical neuroscience


Details

No. of pages:
352
Language:
English
Copyright:
© Elsevier 2016
Published:
Imprint:
Elsevier
eBook ISBN:
9780128029909
Hardcover ISBN:
9780128029732

About the Series Volume Editors

Caterina Rosano Series Volume Editor

Dr. Rosano is Professor of Epidemiology at the University of Pittsburgh, Pittsburgh USA. Dr. Rosano's research integrates methods from the fields of neuroimaging, geriatric medicine, epidemiology and neuroscience to implement novel strategies for improving brain health and function. Her work to date has characterized and contrasted “normal” brain aging in older adults and “accelerated” brain aging in adults exposed to chronic diseases.

Affiliations and Expertise

Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA

M. Arfan Ikram Series Volume Editor

Dr. Ikram is associate professor of Neuroepidemiology at the Erasmus University Medical Center in Rotterdam, the Netherlands. He is principal investigator of the Rotterdam Study and of the neurology core of the Rotterdam Study. His focus is on understanding the occurrence causes, pre-clinical phase and prognosis of neurological disease in late life, thereby focusing particularly on dementia and its subtypes, stroke, Parkinson's disease.

Affiliations and Expertise

Department of Neuroepidemiology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands

Mary Ganguli Series Volume Editor

Mary Ganguli, MD, MPH, FRCP(C), is Professor of Psychiatry, Neurology, and Epidemiology at the University of Pittsburgh (Pittsburgh, PA, USA). She specializes in geriatric psychiatry and psychiatric epidemiology. She has for the past 30 years conducted large-scale population studies in the USA and in India, focused on the epidemiology of cognitive impairment and dementia in older adults. She has published extensively on these topics, served on editorial boards and as associate editor for several journals, on work groups of the American Psychiatric Association and the American Academy of Neurology, and as grant reviewer for the National Institutes of Health and other funding agencies.

Affiliations and Expertise

Professor of Psychiatry, Epidemiology, and Neurology, University of Pittsburgh, Pittsburgh, PA, USA